gsk_hq

GSK’s Volibris gets pulmonary arterial hypertension approval in Europe

October 26, 2015
Research and Development, Sales and Marketing EMA, GSK

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion …

imprimis_logo

Imprimis launches low-cost Daraprim alternative

October 26, 2015
Sales and Marketing Daraprim, Imprimis, Martin Skhreli, turing

Imprimis Pharmaceuticals has announced that it has made available a customisable compounded formulation of pyrimethamine and leucovorin accessible for physicians …

valeant_logo_on_board

CEO prepares for day of reckoning over Valeant fraud allegations

October 26, 2015
Sales and Marketing J. Michael Pearson, Valeant

Troubled Valeant Pharmaceuticals last week announced strong third quarter revenues, reporting a 36% increase in revenues to $172 million, but …

robert_langer

Puretech Health co-founder and board member Dr Robert Langer wins global engineering prize

October 26, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Dr Robert Langer, Engineering, PureTech Health, Queen Elizabeth engineering prize

Dr Robert Langer, the co-founder of PureTech Health, has won the Queen Elizabeth prize for engineering.The award is in recognition …

AZ sign

FDA backs AZ gout drug despite safety concerns

October 26, 2015
Sales and Marketing AstraZeneca, Zurampic, gout, lesinurad

FDA reviewers have recommended approving AstraZeneca’s new gout therapy Zurampic, which the company purchased in a $1.3 billion buyout, despite …

shire_image_4

Shire reports 7% product sales growth, continues Baxalta pursuit

October 23, 2015
Sales and Marketing Baxalta, Shire

Shire has exceeded market expectations as it reported an 11% rise in Q3 earnings on Friday, driven by product sales, …

cosentyx_logo

Novartis’ Cosentyx gets European approval for two conditions

October 23, 2015
Medical Communications, Sales and Marketing Cosentyx, European Medicines Agency, Novartis, psoriatic arthritis

The scientific committee of the European Medicines Agency (EMA) has recommended the approval of Novartis’ Cosentyx (secukinumab) for treatment of ankylosing …

amgen_hq

Amgen skin cancer drug gets European approval

October 23, 2015
Research and Development Amgen, Imlygic, melanoma, skin cancer

Amgen’s Imlygic (talimogene laherparepvec) has been approved by the scientific committee of the European Medicines Agency (EMA) for the treatment of adults …

richard_erwin

New general manager for Roche UK

October 23, 2015
Medical Communications

Richard Erwin has joined Roche as the new UK General Manager.Richard’s passion for driving sustainable change and championing patient needs …

Viekira Pak logo

FDA warns AbbVie hep C drugs linked to serious liver damage

October 23, 2015
Medical Communications AbbVie

AbbVie stocks tumbled 14% yesterday after the FDA warned that two of the company’s hepatitis C drugs could cause serious …

OLS backs UK to become global digital health leader

October 23, 2015
Medical Communications Big Data, Office for Life Sciences, digital health, health analytics, mhealth, patient records, telehealth, telehealthcare

The UK market has the potential to lead the world in digital health – if certain barriers are overcome – …

New Merck logo

COMPANY PROFILE: The secrets of that Merck rebrand

October 23, 2015
Medical Communications, Sales and Marketing Merck, branding, communications, corporate logo, reputation

Merck’s recent rebrand may have left many scratching their heads, as the company moved away from the clinical professionalism of …

gilead-sciences

Gilead presents Phase III results for Genvoya in HIV

October 22, 2015
Medical Communications, Research and Development Genvoya, Gilead Sciences, HIV

Gilead Sciences has today announced 96-week results from two Phase III studies evaluating its investigational once-daily single tablet regimen (STR), …

bmss_orencia_was_recommended_in_draft_guidance

NICE recommends four treatments for arthritis in children

October 22, 2015
Medical Communications, Research and Development NICE, arthritis, jia

 UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …

bmss_orencia_was_recommended_in_draft_guidance

NICE recommends four treatments for arthritis in children

October 22, 2015
Medical Communications, Research and Development NICE, arthritis, jia

 UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …

uk_china_flags_half_and_half

UK and China sign £2 billion in healthcare trade and investment deals

October 22, 2015
Research and Development

More than £2 billion of healthcare trade deals and collaborations have been signed between Chinese and UK companies, universities, and …

pi

Physicians Interactive acquires Univadis portal

October 22, 2015
Medical Communications, Sales and Marketing Merck, Physicians Interactive, Univadis

Digital marketing firm Physicians Interactive (PI) has acquired the Univadis medical information platform, in a move which it says creates …

mgt_kingsley

Executive vice president Tony Kingsley leaves Biogen

October 22, 2015
Biogen, John Cox, Tony Kingsley

Biogen has begun the search for a replacement for Tony Kingsley, former executive vice president of global commercial operations.Kingsley will …

Severin Schwan

Roche buoyed by 6% sales growth

October 22, 2015
Sales and Marketing Roche, financial results

Roche has reported strong sales growth for the first nine months of 2015 and revised its sales outlook to reflect …

Aspirin

World’s largest clinical trial of aspirin in cancer launches in UK

October 22, 2015
Research and Development CRUK, Cancer, Cancer Research UK, aspirin, clinical trial, phase III

The world’s largest ever clinical trial has been launched across the UK today, to discover whether taking aspirin every day …

The Gateway to Local Adoption Series

Latest content